IBDEI0L5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9869,0)
 ;;=H40.033^^44^496^1
 ;;^UTILITY(U,$J,358.3,9869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9869,1,3,0)
 ;;=3^Anatomical Narrow Angle,Bilateral
 ;;^UTILITY(U,$J,358.3,9869,1,4,0)
 ;;=4^H40.033
 ;;^UTILITY(U,$J,358.3,9869,2)
 ;;=^5005734
 ;;^UTILITY(U,$J,358.3,9870,0)
 ;;=H40.041^^44^496^123
 ;;^UTILITY(U,$J,358.3,9870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9870,1,3,0)
 ;;=3^Steroid Responder,Right Eye
 ;;^UTILITY(U,$J,358.3,9870,1,4,0)
 ;;=4^H40.041
 ;;^UTILITY(U,$J,358.3,9870,2)
 ;;=^5005736
 ;;^UTILITY(U,$J,358.3,9871,0)
 ;;=H40.042^^44^496^122
 ;;^UTILITY(U,$J,358.3,9871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9871,1,3,0)
 ;;=3^Steroid Responder,Left Eye
 ;;^UTILITY(U,$J,358.3,9871,1,4,0)
 ;;=4^H40.042
 ;;^UTILITY(U,$J,358.3,9871,2)
 ;;=^5005737
 ;;^UTILITY(U,$J,358.3,9872,0)
 ;;=H40.051^^44^496^76
 ;;^UTILITY(U,$J,358.3,9872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9872,1,3,0)
 ;;=3^Ocular Hypertension,Right Eye
 ;;^UTILITY(U,$J,358.3,9872,1,4,0)
 ;;=4^H40.051
 ;;^UTILITY(U,$J,358.3,9872,2)
 ;;=^5005740
 ;;^UTILITY(U,$J,358.3,9873,0)
 ;;=H40.052^^44^496^75
 ;;^UTILITY(U,$J,358.3,9873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9873,1,3,0)
 ;;=3^Ocular Hypertension,Left Eye
 ;;^UTILITY(U,$J,358.3,9873,1,4,0)
 ;;=4^H40.052
 ;;^UTILITY(U,$J,358.3,9873,2)
 ;;=^5005741
 ;;^UTILITY(U,$J,358.3,9874,0)
 ;;=H40.053^^44^496^74
 ;;^UTILITY(U,$J,358.3,9874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9874,1,3,0)
 ;;=3^Ocular Hypertension,Bilateral
 ;;^UTILITY(U,$J,358.3,9874,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,9874,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,9875,0)
 ;;=H40.061^^44^496^106
 ;;^UTILITY(U,$J,358.3,9875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9875,1,3,0)
 ;;=3^Primary Angle-Closure w/o Glaucoma Damage,Right Eye
 ;;^UTILITY(U,$J,358.3,9875,1,4,0)
 ;;=4^H40.061
 ;;^UTILITY(U,$J,358.3,9875,2)
 ;;=^5005744
 ;;^UTILITY(U,$J,358.3,9876,0)
 ;;=H40.062^^44^496^107
 ;;^UTILITY(U,$J,358.3,9876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9876,1,3,0)
 ;;=3^Primary Angle-Closure w/o Glaucoma Damage,Left Eye
 ;;^UTILITY(U,$J,358.3,9876,1,4,0)
 ;;=4^H40.062
 ;;^UTILITY(U,$J,358.3,9876,2)
 ;;=^5005745
 ;;^UTILITY(U,$J,358.3,9877,0)
 ;;=H40.10X0^^44^496^81
 ;;^UTILITY(U,$J,358.3,9877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9877,1,3,0)
 ;;=3^Open-Angle Glaucoma,Stage Unspec
 ;;^UTILITY(U,$J,358.3,9877,1,4,0)
 ;;=4^H40.10X0
 ;;^UTILITY(U,$J,358.3,9877,2)
 ;;=^5005748
 ;;^UTILITY(U,$J,358.3,9878,0)
 ;;=H40.10X1^^44^496^78
 ;;^UTILITY(U,$J,358.3,9878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9878,1,3,0)
 ;;=3^Open-Angle Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,9878,1,4,0)
 ;;=4^H40.10X1
 ;;^UTILITY(U,$J,358.3,9878,2)
 ;;=^5005749
 ;;^UTILITY(U,$J,358.3,9879,0)
 ;;=H40.10X2^^44^496^79
 ;;^UTILITY(U,$J,358.3,9879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9879,1,3,0)
 ;;=3^Open-Angle Glaucoma,Moderate Stage
 ;;^UTILITY(U,$J,358.3,9879,1,4,0)
 ;;=4^H40.10X2
 ;;^UTILITY(U,$J,358.3,9879,2)
 ;;=^5005750
 ;;^UTILITY(U,$J,358.3,9880,0)
 ;;=H40.10X3^^44^496^80
 ;;^UTILITY(U,$J,358.3,9880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9880,1,3,0)
 ;;=3^Open-Angle Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,9880,1,4,0)
 ;;=4^H40.10X3
 ;;^UTILITY(U,$J,358.3,9880,2)
 ;;=^5005751
 ;;^UTILITY(U,$J,358.3,9881,0)
 ;;=H40.10X4^^44^496^77
 ;;^UTILITY(U,$J,358.3,9881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9881,1,3,0)
 ;;=3^Open-Angle Glaucoma,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,9881,1,4,0)
 ;;=4^H40.10X4
 ;;^UTILITY(U,$J,358.3,9881,2)
 ;;=^5005752
